Newsroom

HONG KONG--(BUSINESS WIRE)--MultiBank Group, il più grande e regolamentato istituto di derivati finanziari al mondo, è orgoglioso di annunciare che l'atteso token $MBG sarà quotato presso due nuove Borse globali di criptovalute di alto livello: MEXC e Gate.io, nel giorno del Token Generation Event (TGE) ufficiale, in programma il 22 luglio 2025, oltre alla quotazione su MultiBank.io e Uniswap. Il token $MBG prenderà il via su: MultiBank.io Gate.io MEXC Uniswap Questa nuova doppia quotazione con...

HONG KONG--(BUSINESS WIRE)--MultiBank Group, la institución de derivados financieros más grande y regulada del mundo, se enorgullece de anunciar que su muy esperado token $MBG cotizará en dos nuevas bolsas de criptomonedas globales importantes, MEXC y Gate.io, a partir del día de su Evento de Generación de Tókenes (TGE, por sus siglas en inglés) oficial, el 22 de julio de 2025, además de MultiBank.io y Uniswap. El token $MBG estará disponible en: MultiBank.io Gate.io MEXC Uniswap Esta nueva dob...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV) common stock between November 10, 2023 and February 27, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON DOUBLEVERIFY HOLDINGS, INC. (DV), CLICK HERE TO P...

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 17 July 2025 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Compan...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the “Class Period”). Biohaven investors have until September 12, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BIOHAVEN LTD. (BHVN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPA...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, brought together more than 4,000 community pharmacy owners, industry experts and partners for its flagship annual tradeshow and conference, ThoughtSpot. Now in its 14th year, ThoughtSpot serves as a celebration of Good Neighbor Pharmacy and its member pharmacies, recognizing their unwavering commitment to improving community health and advancing the future of phar...

CLEVELAND, OHIO--(BUSINESS WIRE)--The Board of Directors of Park-Ohio Holdings Corp. (NASDAQ: PKOH) has declared a quarterly cash dividend of $0.125 per share on the common stock outstanding, to be paid on August 15, 2025, to shareholders of record as of the close of business on August 1, 2025. ParkOhio is a diversified international company providing world-class customers with a supply chain management outsourcing service, capital equipment used on their production lines, and manufactured comp...

ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”) will release second quarter 2025 financial results after the market close on Wednesday, August 6, 2025. Management will host a conference call to discuss results on Thursday, August 7, at 8:30 a.m. Eastern Time. Participants should plan to access the call 15 minutes prior to the start time to ensure a smooth connection. Details are as follows: Dial in Number Passcode Time/Date Conference call     800-753-0725 (Tollfree) +...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for Genentech’s supplemental Biologics License Application (sBLA) for Columvi® (glofitamab-gxbm) in combination with gemcitabine and oxaliplatin (GemOx) for the treatment of people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are not candidates for...

DALLAS--(BUSINESS WIRE)--Dallas-based Nachawati Law Group is working with Kentucky Attorney General Russell Coleman’s Office in a lawsuit against Temu, the Chinese-owned shopping app accused of sweeping users’ personal data, violating consumer privacy laws and selling counterfeit goods. Through promises of bargain-basement prices on a dizzying array of consumer and household goods, the Temu shopping app has become one of the most popular apps in the United States. However, the app also collects...